è±åœæ¿åºã®å€±æã«ãããä»è·æœèšã§COVIDããéç«ã®ããã«ãåºãã£ãããšã調æ»ã§å€æããã
ä»è·éšéã¯Covid-19ãã³ãããã¯ã®éãåŸåããã«ãããæ¿åºã®å€±æã«ãã£ãŠãŠã€ã«ã¹ãè匱ãªäººã
ãé«éœ¢è
ã®éã§ãéç«ã®ããã«ãåºãã£ããšãå
¬ç調æ»ãèªå®ãããCovid-19調æ»ãçãããã¶ãŒã»ãã¬ããæ°ã¯ãç
é¢ããä»è·æœèšãžéé¢ããæ£è
ãéé¢ãã¹ãã ãšããå©èšãæ¿åºãè¡ããªãã£ãããšã¯ãé倧ãªçç¥ãã§ããããŠã€ã«ã¹ãå
¥å±
è
ãšè·å¡ã®éã§æ¥éã«åºããåå ã«ãªã£ããšè¿°ã¹ãã圌女ã¯ãŸããä»è·æœèšãžã®é¢äŒãçŠæ¢ããããšãå
¥å±
è
ã«ãèšãç¥ããªã粟ç¥ç害ããããããããæ·±ãå€ç«ãšèŠæšãŠãããæèŠããæ®ãããšãè¿°ã¹ãããæäººç€ŸäŒã±ã¢éšéå
šäœãã©ã¡ãããšããã°åŸåãã®ããã«èŠãããNHSãå®ãããšããã¹ããŒã¬ã³ãæã«ã±ã¢ã®å©çšè
ãšæäŸè
ãç ç²ã«ããŠå±ããããããšåœŒå¥³ã¯è¿°ã¹ãããä»è·æœèšã¯æãå¿
èŠãšããŠããæã«ååãªä¿è·ãåããããªãã£ãããããã®å€±æãããŠã€ã«ã¹ãéç«ã®ããã«åºããåŸãç°å¢ãã±ã¢çŸå Žã«çã¿åºãããæãæ²çãªããšã«ãæ»æã®è¿«ã£ãæãã人ãšå
±ã«ããããšãèš±ãããªãã£ã人ã
ããããå€ãã®äººããèè² ãå¿
èŠã®ãªãçœªæªæã«ä»ãèŠãããããŠãããã2020幎3æãã2022幎7æã®éã«ãè±åœã®ä»è·æœèšã§43,000人以äžãCovid-19ã§æ»äº¡ãããç«ææ¥ã«å
¬è¡šããããã¬ãã女å²ã®å ±åæžã¯ãæäººç€ŸäŒã±ã¢ãšå±
äœåæœèšã«ç¹ã«çŠç¹ãåœãŠãŠããã調æ»ãå
¬è¡šãã10æ¬ã®ãã¡6æ¬ç®ã§ãããããã¯ååœå²äžæãè²»çšã®ãããå
¬ç調æ»ã§ãããè²»çšã¯2åãã³ããè¶
ãããããŸã§ã«å°æ¥ã®ãã³ãããã¯ãžã®åããããè¯ãããæ¹æ³ã«ã€ããŠ55ã®å§åãè¡ã£ãŠãããå
ä¿å¥å€§è£ã®ãããã»ãã³ã³ãã¯æ°ã¯èšŒèšãæ±ãããããã³ãããã¯åæã«æ€æ»ãåããŠããªãç
颿£è
ãä»è·æœèšãžéé¢ãããæ¿åºæ±ºå®ã®è²¬ä»»ãè² ã£ãã2020幎3æãš4æã«ã2020幎4æ15æ¥ã«çŸ©åçæ€æ»ãå°å
¥ãããåã«ãNHSã®ç
åºã空ãããããã€ã³ã°ã©ã³ãåå°ã§çŽ25,000人ã®ç
颿£è
ãä»è·æœèšãžéé¢ãããããããã®æ¿çã¯åŸã«é«çæ³é¢ã«ãã£ãŠéæ³ãšå€æ±ºãããããã³ã³ãã¯æ°ã¯èª¿æ»ã«å¯Ÿããããã¯ãã²ã©ãåé¡ã«å¯Ÿããæãæªããªã決å®ãã ã£ããšè¿°ã¹ãããã¬ããæ°ã¯ãç
åºã空ããããã«ãã®æ¿çã¯å¿
èŠã ã£ããšãã€ã€ãé颿£è
ãéé¢ããããä»è·æœèšã«å©èšããªãã£ãæ¿åºãæ¹å€ããã圌女ã¯ãŸãããã³ãããã¯éå§æããä»è·æœèšã®åšãã«ãä¿è·ã®èŒªãã匵ã£ããšãããã³ã³ãã¯æ°ã®é·å¹Žã®äž»åŒµãéãããæ ¹æ ããªãããšè¿°ã¹ãã圌女ã¯å ±åæžã§8ã€ã®äž»èŠãªå§åãè¡ã£ãŠãããããã«ã¯ããè¯ããã³ãããã¯èšç»ã瀟äŒã±ã¢è·å¡ã®èªå·±éé¢ãå©ããè²¡æ¿æ¯æŽãé¢äŒå¶éã«é¢ããæéãããã¯ããŠã³äžã®ããè¯ãæ»å¯ãå«ãŸããã圌女ã®å ±åæžã¯ãŸããä»è·æœèšè·å¡åãã®å人é²è·å
·ïŒPPEïŒã®äžè¶³ãå³ããæ¹å€ããããŸã£ããåãå
¥ããããªãããšè¿°ã¹ãŠããã圌女ã¯ã人ã
ãããã§ã¹ãã£ãã«çšã®é²æ°Žãã³ãã§ãå¡è£
å·¥ã®ã€ãªãæãDIYåºã§è³Œå
¥ããæè¢ãã䜿ãããšã«é Œã£ãããšããŸãåžããã¿è¢ãå¯å
·çšãªãã³ããèªäœã®PPEãäœã£ãããšãæåããŠããã圌女ã¯è·å¡ãžã®ç²Ÿç¥çè² æ
ã«ãèšåããã瀟äŒã±ã¢è·å¡ãç®æããæ»ãšèŠãã¿ã®èŠæš¡ã¯ïŒ»âŠïŒœåœŒãããããŸã§èŠãäœãšãç°ãªã£ãŠããããšè¿°ã¹ãããã¬ããæ°ã¯ããããå¿çå€å·åŸã¹ãã¬ã¹ãèªæ®ºå¿µæ
®ã«ã€ãªãããå€ãã®ã±ã¢åŽåè
ãèªãåœãçµ¶ã£ããšè¿°ã¹ãŠããããæäººç€ŸäŒã±ã¢ã®åŽåè
ãšå©çšè
ãå®ãããšããè±åœæ¿åºããã³æš©éå§è²æ¿åºã®è¡åã¯é
ããããç§ã®å§åã¯ã次ã®ãã³ãããã¯ã襲ãåã«ä»ããå®è¡ãããªããã°ãªããªãããšåœŒå¥³ã¯è¿°ã¹ãããããã質å以äžã¯ãæ¿åºã®å€±æã«ãã£ãŠCovidãä»è·æœèšã§éç«ã®ããã«åºããããšãèš±ãããšããè±åœCovid調æ»ã®èªå®ã«é¢ããFAQã§ã 1 è±åœCovid調æ»ã¯å®éã«äœãèªå®ããã®ã 調æ»ã¯ãè±åœæ¿åºããã³ãããã¯äžã«ä»è·æœèšãžã®åããšä¿è·ãæ ã£ããšçµè«ã¥ããããã®éã¡ââé
ãè¡åãäžååãªæ€æ»ãé©åãªç¢ºèªãªãã®ç
颿£è
ã®éé¢ââãããŠã€ã«ã¹ãè匱ãªå
¥å±
è
ã®éã§æ¥éã«åºããã®ãå©ãã 2 ããã§ãéç«ã®ããã«åºããããšã¯ã©ãããæå³ã ããã¯ãCovidãã©ãã»ã©æ¥éã«ä»è·æœèšãåžå·»ãããã«ã€ããŠã®èª¿æ»ã®è¡šçŸã§ãããçãå±
äœç©ºéãå
±æã®è·å¡ãæ€æ»ã®æ¬ åŠã«ããã1ã€ã®ææãæ°æ¥ã§æœèšå
šäœã«åºããåŸã 3 ãªãä»è·æœèšã¯ããã»ã©è匱ã ã£ãã®ã å
¥å±
è
ã¯ãã°ãã°é«éœ¢ãŸãã¯äœèª¿äžè¯ã§ããããããŠã€ã«ã¹ãæãåŒ·ãææãäžãããè·å¡ã¯å
¥å±
è
ã®éãç§»åããåæã«ã¯æ€æ»ãé²è·å
·ãæéãã»ãšãã©ãªãã£ãããã®çµã¿åãããæœèšããŠã€ã«ã¹ã®æ Œå¥œã®æšçã«ãã 4 äž»ãªæ¿åºã®å€±æã¯äœã ã£ãã®ã äž»ãªå€±æã«ã¯ãä»è·æœèšã«å¯Ÿããããã¯ããŠã³ãšå¶éã®é
å»¶ãCovidæ€æ»ãªãã§ç
颿£è
ãæœèšãžéã£ãããšãé²è·å
·ã®äžè¶³ãåŒ±ãæ€æ»ãšææç®¡çã®æéãå«ãŸãã 5 ãªãç
颿£è
ãä»è·æœèšãžéé¢ãããããšãããã»ã©é倧ãªã®ã ãã³ãããã¯åæã«ãæ£è
ã¯Covidæ€æ»ãåããã«ç
é¢ããä»è·æœèšãžç§»ããããäžéšã¯ãŠã€ã«ã¹ãéã³èŸŒã¿ãææã®ãªãã£ãæœèšã§éå£çºçã®çš®ããŸãã 6 PPEãšã¯äœã§ããªãéèŠã PPEã¯å人é²è·å
·ãæå³ãããã¹ã¯ãæè¢ãã¬ãŠã³ããã§ã€ã¹ã·ãŒã«ãã§ãããè·å¡ãå
¥å±
è
ã«ãŠã€ã«ã¹ãç§»ãããŸããã®éãé²ããåæã®äžè¶³ãã±ã¢åŽåè
ãå±éºã«ãããã 7 æ¿åºã¯æåãä»è·æœèšãç¡èŠããã®ã 調æ»ã¯ãä»è·æœèšãåŸåãã«æ±ããããšèªå®ãããæéãšæ¯æŽã¯NHSã«éäžããæããªã¹ã¯ã®é«ã人ã
ãæ±ããŠããã«ãããããããä»è·æœèšãžã®æ¯æŽã¯é
ãã 8 å
¬ç調æ»ãšã¯äœã§ãäœãããã®ã å
¬ç調æ»ã¯é倧ãªåºæ¥äºã«å¯Ÿããå
¬åŒã®ç¬ç«ãã調æ»ã§ããã蚌æ ãéãã蚌人ããèãåãã調æ»çµæãšå§åãå
¬è¡šãããã誰ãã蚎远ãããæ¿åºã«è¡åã匷å¶ãããã¯ã§ããªã 9 è±åœCovid-19調æ»ãšã¯äœã è±åœã®ãã³ãããã¯å¯Ÿå¿ã«é¢ããå
¬åŒèª¿æ»ã§ããããã¬ããç·çµå€«äººãè°é·ãåãããåããæææ±ºå®ãããŸããŸãªéå£ãžã®åœ±é¿ãæ€èšãã